Skip to main content
ARS Home » Midwest Area » Ames, Iowa » National Animal Disease Center » Ruminant Diseases and Immunology Research » Research » Publications at this Location » Publication #263631
Title: Are proteomic technologies ready for IVDs

Author
item Tabatabai, Louisa

Submitted to: In Vitro Diagnostic Technology
Publication Type: Abstract Only
Publication Acceptance Date: 4/11/2011
Publication Date: 4/21/2011
Citation: Tabatabai, L.B. 2011. Are proteomic technologies ready for IVDs [abstract]. In Vitro Diagnostic Technology. Available: www.ubmcanon.com/epromos/2011/IV/18758_IV11_PaidWebcast/images/header.jpg.

Interpretive Summary:

Technical Abstract: During the last decade as a result of the unparalleled advancements in mass spectrometry-based methods in protein analysis, biomarker research has escalated to new heights in the academic, government and industrial research laboratories. Translation of biomarker research to in vitro diagnostics (IVD), however, presents new challenges to both research laboratory and the Food and Drug Administration to move biomarker research forward to critically needed devices for the clinical hospital laboratory and the medical community for screening purposes, pre-treatment decisions, identification of specific diseases, and post-treatment monitoring.